{"id":3121,"date":"2022-02-04T12:35:38","date_gmt":"2022-02-04T12:35:38","guid":{"rendered":"https:\/\/blogs-staging.imperial.ac.uk\/surgeryandcancer\/?p=3121"},"modified":"2022-02-04T12:42:02","modified_gmt":"2022-02-04T12:42:02","slug":"dr-amelia-seifalian-wins-2022-young-innovator-award","status":"publish","type":"post","link":"https:\/\/blogs-staging.imperial.ac.uk\/surgeryandcancer\/2022\/02\/04\/dr-amelia-seifalian-wins-2022-young-innovator-award\/","title":{"rendered":"Dr Amelia Seifalian wins 2022 Young Innovator Award"},"content":{"rendered":"<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/blogs-staging.imperial.ac.uk\/surgeryandcancer\/files\/2022\/02\/1643283354287.jpeg\"><img loading=\"lazy\" decoding=\"async\" width=\"1600\" height=\"900\" class=\"aligncenter wp-image-3125 size-full\" src=\"https:\/\/blogs-staging.imperial.ac.uk\/surgeryandcancer\/files\/2022\/02\/1643283354287.jpeg\" alt=\"\" \/><\/a><\/p>\n<p>Congratulations to S&amp;C&#8217;s Dr Amelia Seifalian who won the 2022 Young Innovator award from Innovate UK.<\/p>\n<p><!--more--><\/p>\n<p>Dr Amelia Seifalian is a junior NHS doctor and a part-time PhD student in S&amp;C, under the supervision of <a href=\"https:\/\/www.imperial.ac.uk\/people\/nagy.habib\">Prof Nagy Habib<\/a> and <a href=\"https:\/\/www.imperial.ac.uk\/people\/vik.khullar\">Prof Vik Khullar<\/a> (Urogynaecology).<\/p>\n<p>Her project is on the development of a novel pelvic implant to treat prolapse using graphene-based nanocomposite materials and stem cell technology. The award, supported by <a href=\"https:\/\/www.gov.uk\/government\/organisations\/innovate-uk\">Innovate\u00a0UK<\/a>, <a href=\"https:\/\/ktn-uk.org\/\">KTN<\/a>, <a href=\"https:\/\/www.ukri.org\/\">UK Research and Innovation<\/a>, and the <a href=\"https:\/\/www.gov.uk\/government\/organisations\/department-for-business-energy-and-industrial-strategy\">Department for Business, Energy and Industrial Strategy (BEIS)<\/a>, will include funding to support the development of her idea<\/p>\n<p>Pelvic organ prolapse affects half of women worldwide. A previous, unsuccessful treatment using a polypropylene-based mesh resulted in a ban. Amelia is in the early stages of researching a substitute product that would be made using graphene-based nanocomposite material. At the same time, she is proposing stem cell technology to overcome previous issues with the mesh treatment and provide a potential cure for the condition.<\/p>\n<p>Speaking about the award, Amelia said: &#8220;It is such an honour to have this fantastic award to accelerate the start of my PhD project at\u00a0<a href=\"https:\/\/www.linkedin.com\/company\/imperial-college-london\/\" data-attribute-index=\"2\" data-entity-hovercard-id=\"urn:li:fs_miniCompany:5106\" data-entity-type=\"MINI_COMPANY\">Imperial College London<\/a> developing a novel surgical adjunct for pelvic organ prolapse surgery using graphene-based nanocomposite materials (Hastalex\u00ae) and stem cell technology.&#8221;<\/p>\n<p>Amelia already has a track record in the application of nanotechnology in medicine, having published over a dozen papers in the field. Given the success with her proposed membrane, her goal is to go on to develop further products with the potential to revolutionise healthcare.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; Congratulations to S&amp;C&#8217;s Dr Amelia Seifalian who won the 2022 Young Innovator award from Innovate UK.<\/p>\n","protected":false},"author":1343,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3121","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/blogs-staging.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/3121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs-staging.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs-staging.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs-staging.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/users\/1343"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs-staging.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/comments?post=3121"}],"version-history":[{"count":7,"href":"https:\/\/blogs-staging.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/3121\/revisions"}],"predecessor-version":[{"id":3130,"href":"https:\/\/blogs-staging.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/3121\/revisions\/3130"}],"wp:attachment":[{"href":"https:\/\/blogs-staging.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/media?parent=3121"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs-staging.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/categories?post=3121"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs-staging.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/tags?post=3121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}